Hungry Bone Syndrome in Peritoneal Dialysis Patients After Parathyroid Surgery

Overview

Journal Endocr Connect

Specialty Endocrinology

Date 2023 Aug 22

PMID 37606078

Authors

Heng Yeh

Hsuan Yeh

Chun-Cheng Chiang

Ju-Ching Yen

I-Kuan Wang

Shou-Hsuan Liu

Cheng-Chia Lee

Cheng-Hao Weng

Wen-Hung Huang

Ching-Wei Hsu

Tzung-Hai Yen

Affiliations

Soon will be listed here.

Abstract

Secondary hyperparathyroidism (SHPT) is a common complication of end-stage kidney disease (ESKD). Hungry bone syndrome (HBS) occurs frequently in patients on maintenance dialysis receiving parathyroidectomy for refractory SHPT. However, there is scanty study investigating the clinical risk factors that predict postoperative HBS, and its outcome in peritoneal dialysis (PD) patients. We conducted a single-center retrospective study to analyze 66 PD patients who had undergone parathyroidectomy for secondary hyperparathyroidism at Chang Gung Memorial Hospital between 2009 and 2019. The patients were stratified into two groups based on the presence (n=47) or absence (n=19) of HBS after parathyroidectomy. Subtotal parathyroidectomy was the most common surgery performed (74.2%), followed by total parathyroidectomy with autoimplantation (25.8%). Pathological examination of all surgical specimens revealed parathyroid hyperplasia (100%). Patients with HBS had lower levels of postoperative nadir corrected calcium, higher alkaline phosphate (ALP), and higher potassium levels compared with patients without HBS (all P<0.05). A multivariate logistic regression model confirmed that lower preoperative serum calcium level (OR 0.354, 95% CI 0.133-0.940, P=0.037), higher ALP (OR 1.026, 95% CI 1.008-1.044, P=0.004), and higher potassium level (OR 6.894, 95% CI 1.806-26.317, P=0.005) were associated with HBS after parathyroidectomy. Patients were followed for 58.2±30.8 months after the surgery. There was no significant difference between HBS and non-HBS groups in persistence (P=0.496) or recurrence (P=1.000) of hyperparathyroidism. The overall mortality rate was 10.6% with no significant difference found between both groups (P=0.099). We concluded that HBS is a common complication (71.2%) of parathyroidectomy for SHPT and should be managed appropriately.

References

Jofre R, Lopez Gomez J, Menarguez J, Polo J, Guinsburg M, Villaverde T . Parathyroidectomy: whom and when?. Kidney Int Suppl. 2003; (85):S97-100. DOI: 10.1046/j.1523-1755.63.s85.23.x. View

Liu Y, Cheng B, Lee W, Li L, Lee C, Chang W . Serum Potassium Profile and Associated Factors in Incident Peritoneal Dialysis Patients. Kidney Blood Press Res. 2016; 41(5):545-551. DOI: 10.1159/000443457. View

Timofte D, Tanasescu M, Balcangiu-Stroescu A, Balan D, Tulin A, Stiru O . Dyselectrolytemia-management and implications in hemodialysis (Review). Exp Ther Med. 2020; 21(1):102. PMC: 7725007. DOI: 10.3892/etm.2020.9534. View

Juul S, Yachnis A, Christensen R . Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev. 1998; 52(3):235-49. DOI: 10.1016/s0378-3782(98)00030-9. View

Mittendorf E, Merlino J, McHenry C . Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg. 2004; 70(2):114-9. View

Steffen L, Moffa G, Muller P, Oertli D . Secondary hyperparathyroidism: recurrence after total parathyroidectomy with autotransplantation. Swiss Med Wkly. 2019; 149:w20160. DOI: 10.4414/smw.2019.20160. View

Ge Y, Yang G, Wang N, Zha X, Yu X, Mao H . Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol. 2019; 51(8):1443-1449. DOI: 10.1007/s11255-019-02217-y. View

Liu C, Lin Y, Lin Y, Kao C, Chen H, Hsu C . Roles of Serum Calcium, Phosphorus, PTH and ALP on Mortality in Peritoneal Dialysis Patients: A Nationwide, Population-based Longitudinal Study Using TWRDS 2005-2012. Sci Rep. 2017; 7(1):33. PMC: 5428378. DOI: 10.1038/s41598-017-00080-4. View

Elliott A, Soliman K, Ullian M . Hyperkalemia in chronic peritoneal dialysis patients. Ren Fail. 2022; 44(1):217-223. PMC: 8856104. DOI: 10.1080/0886022X.2022.2032151. View

10.

Wang Q, Li X, Chen H, Yu H, Li L, Yin J . The chloride/phosphate ratio combined with alkaline phosphatase as a valuable predictive marker for primary hyperparathyroidism in Chinese individuals. Sci Rep. 2017; 7(1):4868. PMC: 5501820. DOI: 10.1038/s41598-017-05183-6. View

11.

Jain N, Reilly R . Hungry bone syndrome. Curr Opin Nephrol Hypertens. 2017; 26(4):250-255. DOI: 10.1097/MNH.0000000000000327. View

12.

Yuen N, Ananthakrishnan S, Campbell M . Hyperparathyroidism of Renal Disease. Perm J. 2016; 20(3):15-127. PMC: 4991918. DOI: 10.7812/TPP/15-127. View

13.

Yang G, Ge Y, Zha X, Mao H, Wang N, Xing C . Peritoneal dialysis can alleviate the clinical course of hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol. 2019; 51(3):535-542. DOI: 10.1007/s11255-019-02076-7. View

14.

Phimphilai M, Inya S, Manosroi W . A predictive risk score to diagnose hypocalcemia after parathyroidectomy in patients with secondary hyperparathyroidism: a 22-year retrospective cohort study. Sci Rep. 2022; 12(1):9548. PMC: 9184730. DOI: 10.1038/s41598-022-13880-0. View

15.

Konturek A, Barczynski M, Stopa M, Nowak W . Subtotal parathyroidectomy for secondary renal hyperparathyroidism: a 20-year surgical outcome study. Langenbecks Arch Surg. 2016; 401(7):965-974. PMC: 5086343. DOI: 10.1007/s00423-016-1447-7. View

16.

Cruz D, Perazella M . Biochemical aberrations in a dialysis patient following parathyroidectomy. Am J Kidney Dis. 1997; 29(5):759-62. DOI: 10.1016/s0272-6386(97)90131-1. View

17.

Kim M, Kim G, Lee C, Park J, Lee J, Tae K . Surgical Outcomes of Subtotal Parathyroidectomy for Renal Hyperparathyroidism. Clin Exp Otorhinolaryngol. 2020; 13(2):173-178. PMC: 7248609. DOI: 10.21053/ceo.2019.01340. View

18.

Zhong A, Billa V, Rotstein L, Wong P, Bargman J, Vas S . Recurrence of hyperparathyroidism after total parathyroidectomy and autotransplantation in peritoneal dialysis patients. Perit Dial Int. 2000; 20(2):200-8. View

19.

Neves K, Graciolli F, Reis L, Graciolli R, Neves C, Magalhaes A . Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int. 2007; 71(12):1262-70. DOI: 10.1038/sj.ki.5002241. View

20.

Latus J, Roesel M, Fritz P, Braun N, Ulmer C, Steurer W . Incidence of and risk factors for hungry bone syndrome in 84 patients with secondary hyperparathyroidism. Int J Nephrol Renovasc Dis. 2013; 6:131-7. PMC: 3709645. DOI: 10.2147/IJNRD.S47179. View